Author: healthylife7

Every antidepressant approved by the FDA — from Prozac to esketamine to the new wave of psychedelic-derived compounds advancing through late-stage trials — acts inside the brain. SSRIs rebalance serotonin at synapses. NMDA antagonists modulate glutamate. Psilocybin remodels neural plasticity. The assumption built into all of them is that depression is, at root, a disorder…

Read More